Tariff-driven volatility has redefined what's considered a "normal" day of bond-market trading, with traders contemplating "a wider scope of conceivable outcomes" as the global trade war unfolds, said ...

The Company intends to use the proceeds of the Offering to advance its Novador Gold project and explore its Québec properties, as well as for working capital. The Offered Securities issued under the ...

Bristol Myers Squibb's drug to treat a type of heart disease did not significantly improve functional capacity and symptoms ...

Yields on long-dated bonds jumped last week, even as equity markets swung wildly. This has fueled bets on a steeper yield ...

The U.S. economy defied worries of recession for the past three years and experienced surprisingly stellar growth. But don't expect a repeat in 2025: Weak or worse are the are only two paths for the ...

The carnage in the stock market following President Donald Trump's April 2 unveiling of sweeping tariffs on virtually all U.S. trade partners has been extraordinary - but it's a historic surge in long ...

As the biopharma industry grapples with the uncertain macro environment brought on by the new administration, CEOs, ...

The economy and the markets are "under surveillance" as we cover the latest in finance, economics and investment.

It’s unclear whether tariffs will influence more companies to make more drugs in the U.S. like President Donald Trump is ...

The S&P 500 (SP500) has faced a rocky start in 2025 which has prompted BMO Capital Markets to lower its year-end target for ...

Trump said he would announce pharmaceutical tariffs, as he increased tariffs on China to 125% and paused tariffs for 75 ...

U.S. corporate bond market issuances have dried up after opening for just one bond offering on Tuesday, as spreads in the ...